Drug Eluting Stents Versus Bare Metal Stents for Treatment of Symptomatic Extracranial Vertebral Artery Stenosis

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.

Also called NCT03201432

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 160 participants (enrolled count) (from the registry)
Sponsor
Xiongjing Jiang (from the registry)
Registry
  • NCT NCT03201432
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03201432. Randomized; no masking; primary purpose treatment. Start 2014-05 (registry gives no type); primary completion 2017-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Drug Eluting Stents Versus Bare Metal Stents for Treatment of Symptomatic Extracranial Vertebral Artery Stenosis
Condition
Vertebral Artery Stenosis
Intervention (Device)
Drug eluting stent (DES)
Intervention (Device)
Bare metal stent (BES)
Lead sponsor
Xiongjing Jiang (class: other)
Collaborator
Yinyi(Liaoning) Biotech Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct03201432
Content hash
b67ce9921fb1891478338345dc850d54486c2de02110b58bb8531fc1d8e0f753